Regentis Biomaterials (NYSEAMERICAN:RGNT – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.22) EPS for the quarter, FiscalAI reports.
Regentis Biomaterials Price Performance
Shares of NYSEAMERICAN:RGNT opened at $1.89 on Friday. Regentis Biomaterials has a 1-year low of $1.23 and a 1-year high of $15.50. The business has a 50-day moving average price of $2.22 and a two-hundred day moving average price of $2.76.
Institutional Investors Weigh In On Regentis Biomaterials
An institutional investor recently bought a new stake in Regentis Biomaterials stock. AIGH Capital Management LLC purchased a new position in shares of Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 300,000 shares of the company’s stock, valued at approximately $916,000. AIGH Capital Management LLC owned about 5.79% of Regentis Biomaterials at the end of the most recent reporting period.
About Regentis Biomaterials
Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing tissue repair solutions which seek to restore the health. Regentis Biomaterials Ltd. is based in Herzliya, Israel.
Recommended Stories
- Five stocks we like better than Regentis Biomaterials
- MarketBeat Week in Review – 09/07 – 09/11
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
Receive News & Ratings for Regentis Biomaterials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regentis Biomaterials and related companies with MarketBeat.com's FREE daily email newsletter.
